GRAFT LOSS

This adverse event was reported 725 times

GRAFT LOSS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTI-THYMOCYTE GLOBULIN (RABBIT) 93 0.0114
1 BELATACEPT 44 0.0093
2 DOXERCALCIFEROL 1 0.0060
3 AUTOLOGOUS CULTURED CHONDROCYTES 2 0.0044
4 VALGANCICLOVIR 61 0.0032
5 ALEMTUZUMAB 59 0.0030
6 CIDOFOVIR ANHYDROUS 4 0.0028
7 TACROLIMUS OINTMENT 0.1% 304 0.0024
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 304 0.0024
9 SIROLIMUS 31 0.0023
See all drugs enriched for association with GRAFT LOSS